|
FBXL15 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.459700E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.343590E-01 |
| Normal-vs-Stage2 |
3.410400E-02 |
| Normal-vs-Stage3 |
1.224360E-01 |
| Normal-vs-Stage4 |
3.467000E-01 |
| Stage1-vs-Stage2 |
1.554430E-01 |
| Stage1-vs-Stage3 |
6.733400E-01 |
| Stage1-vs-Stage4 |
7.972000E-01 |
| Stage2-vs-Stage3 |
3.065400E-01 |
| Stage2-vs-Stage4 |
1.784380E-01 |
| Stage3-vs-Stage4 |
5.767800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.903900E-02 |
| Normal-vs-AfricanAmerican |
1.917900E-02 |
| Normal-vs-Asian |
2.628600E-01 |
| Caucasian-vs-AfricanAmerican |
2.124600E-01 |
| Caucasian-vs-Asian |
7.989000E-01 |
| AfricanAmerican-vs-Asian |
1.663430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.894100E-02 |
| Normal-vs-Female |
1.027550E-01 |
| Male-vs-Female |
4.570200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.046400E-02 |
| Normal-vs-Age(41-60Yrs) |
1.253230E-01 |
| Normal-vs-Age(61-80Yrs) |
1.661810E-01 |
| Normal-vs-Age(81-100Yrs) |
6.080400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.897600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.924600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.990400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.275000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.236400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.167800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.215900E-02 |
| Classical-VS-Follicular |
1.128970E-01 |
| Classical-VS-Other |
5.178800E-01 |
| Classical-VS-Normal |
1.314790E-01 |
| Tall-VS-Follicular |
6.659700E-03 |
| Tall-VS-Other |
9.802300E-02 |
| Tall-VS-Normal |
3.656600E-01 |
| Follicular-VS-Other |
9.050600E-01 |
| Follicular-VS-Normal |
1.905710E-02 |
| Other-VS-Normal |
1.553570E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.181520E-02 |
| Normal-vs-N1 |
5.924100E-02 |
| N0-vs-N1 |
7.242200E-01 |
|
|
